bca101,pembrolizumab,cetuximab
bicara,merck,eli lilly
['bca101', 'cetuximab', 'keytruda', 'hanna', 'bicara']
an important question for bca101: why not just use cetuximab + keytruda? bicara argues hitting tgf-beta as well as egfr deepens responses. dr hanna tells #asco23 that they have seen responses in cetuximab failures, subsequently treated with bca101.
Pharma and biotech reporter, found a home at Evaluate Vantage.